Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Tcr2 Therapeutics Inc (TCRR)

Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Help
Go To:
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy company developing T cell therapies for patients suffering from cancer. Its product candidate includes TC-210, TC-220, TC-410, TC-110 and TC-310 which are in clinical stage. TCR2 Therapeutics Inc. is based in Cambridge, Massachusetts.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Mar, 2023 Dec, 2022 Sep, 2022 Jun, 2022 Mar, 2022
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income -40,400 -60,510 -30,590 -31,600 -29,120
Net Income Growth +33.23% -97.81% +3.20% -8.52% -4.97%

Balance Sheet

(Values in U.S. Thousands) Mar, 2023 Dec, 2022 Sep, 2022 Jun, 2022 Mar, 2022
Total Assets 151,510 208,240 272,930 308,040 323,250
Total Assets Growth -27.24% -23.70% -11.40% -4.71% -0.04%
Total Liabilities 50,180 67,380 74,380 81,780 67,930
Total Liabilities Growth -25.53% -9.41% -9.05% +20.39% +62.16%

Cash Flow

(Values in U.S. Thousands) Mar, 2023 Dec, 2022 Sep, 2022 Jun, 2022 Mar, 2022
Operating Cash Flow -40,010 -101,460 -76,500 -50,670 -31,130
Operating Cash Flow Growth +60.57% -32.63% -50.98% -62.77% +61.85%
Net Cash Flow -18,300 -189,820 -168,560 -178,360 -148,450
Change in Net Cash Flow +90.36% -12.61% +5.49% -20.15% -215.10%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.